Home› India› Ministry of Commerce and Industry› Amendments in Standard Input Output Norms (SION) A 222 for e...
Date: 07-Feb-2025 Category: Extra Ordinary State: Union Government Country: India

Amendments in Standard Input Output Norms (SION) A 222 for export of Erythromycin Stearate Tablet

Issued by Ministry of Commerce and Industry · Directorate General of Foreign Trade

Research with AI Agent Chat with Document Generate Summary Translate Helpful Share Add to Project Create Task

Executive Summary & Key Takeaways

What it means

  • This Public Notice No. 46/2024-25, issued by the Directorate General of Foreign Trade (DGFT), Ministry of Commerce and Industry, amends the Standard Input Output Norms (SION) A-222 concerning the export of Erythromycin Stearate Tablets. The amendment revises the quantity of Erythromycin Stearate required as an input for the export of Erythromycin Stearate tablets.

Key Changes

  • The SION A-222 is amended with immediate effect.
  • For the export of one Erythromycin Stearate 250mg tablet, the permitted import of Erythromycin Stearate is now 334 mg.
  • The notification clarifies that for other variants of export items, norms can be calculated on a pro-rata basis.

Impact Analysis

Impact on Exporters of Erythromycin Stearate Tablets

  • The immediate effect of the amendment requires immediate adjustments to existing export orders and documentation.

Impact on DGFT and Customs Authorities

  • Customs authorities will need to use the revised norms for assessing import requirements for Erythromycin Stearate tablet exports.

Suggested Action Items

  • Customs authorities should update their systems to reflect the changes in SION A-222.

Key Entities Referenced

Directorate General of Foreign Trade (DGFT): The issuing authority for this public notice, responsible for foreign trade policy and its implementation. Ministry of Commerce and Industry: The parent ministry of DGFT, responsible for formulating trade policies. Foreign Trade Policy 2023: The overarching policy framework under which the DGFT exercises its powers. Erythromycin Stearate Tablet: The specific export product to which this notification relates. Standard Input Output Norms (SION) A-222: The specific standard being amended, related to the import of Erythromycin Stearate for export production of Erythromycin Stearate Tablets.
Official Source Record View Original Source →
See Full Document Text
रजिस्ट्री स.ं डी.एल.- 33004/99 REGD. No. D. L.-33004/99 सी.जी.-डी.एल.-अ.-08022025-260850 xxxGIDHxxx CG-DL-E-08022025-260850 xxxGIDExxx असाधारण EXTRAORDINARY भाग I—खण्ड 1 PART I—Section 1 प्राजधकार स ेप्रकाजित PUBLISHED BY AUTHORITY स.ं 39] िई ददल्ली, िुक्रवार, फरवरी 7, 2025/माघ 18, 1946 No. 39] NEW DELHI, FRIDAY, FEBRUARY 7, 2025/MAGHA 18, 1946 वाजणज्य एव ं उद्योग मत्रं ालय (वाजणज्य कर जवभाग) (जवदेि व्यापार महाजिदेिालय) साविव जिक सचू िा नई ददल्ली, 6 फरवरी, 2025 क्र. 46 /2024-25 जवषय: एररथ्रोमाइजसि स्ट्टीयरेट टैबलटे के जियातव के जलए मािक इिपटु आउटपटु मािदडं (जसओि) ए-222 म ेंसिं ोधि। फा. स.ं 01/82/0017/ए एम-25/DES-III.—जवदेि व्यापार िीजत-2023 के पैरा 1.03 और 2.04 के तहत प्रदत्त िजियों का प्रयोग करते हुए, महाजिदेिक जवदेि व्यापार, एररथ्रोमाइजसि स्ट्टीयरेट टैबलेट के जियावत के जलए मािक इिपुट आउटपुट मािदडं (जसओि) ए-222 को जिम्नािुसार संिोजधत दकये िात े ह।ैं जियातव मद मात्रा क्र.स.ं आयात मद मात्रा एररथ्रोमाइजसि स्ट्टीयरेट गोजलयााँ-250 1 िंबर 1 एररथ्रोमाइजसि 334 जमलीग्राम जमलीग्राम। टैबलेट स्ट्टीयरेट (प्रत्येक टैबलेट में एररथ्रोमाइजसि स्ट्टीयरेट 250 जमलीग्राम के बराबर होता ह।ै ) 972 GI/2025 (1)2 THE GAZETTE OF INDIA : EXTRAORDINARY [PART I—SEC.1] िोट: उपरोि जियावत उत्पाद के अन्य प्रकारों के जलए, मािदडं ों की गणिा आिुपाजतक आधार पर की िा सकती ह।ैं साविव जिक सचू िा का प्रभाव: ए-222 के तहत आि े वाल े मािक इिपुट आउटपुट मािदडं को तत्काल प्रभाव से संिोजधत दकया िाता ह।ै संतोष कुमार सारंगी, महाजिदेिक जवदेि व्यापार एवम पदेि अपर सजचव MINISTRY OF COMMERCE AND INDUSTRY (Department of Commerce) (DIRECTORATE GENERAL OF FOREIGN TRADE) PUBLIC NOTICE New Delhi, the 6th February, 2025 No. 46 /2024-25 Subject: Amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet. F. No. 01/82/0017/AM-25/DES-III.— In exercise of the powers conferred under paragraphs 1.03 and 2.04 of the Foreign Trade Policy-2023 as amended from time to time, the Director General of Foreign Trade makes the following amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet. Export Product Quantity Sl. No. Import Item/s Quantity Erythromycin Stearate tablets-250 1 Number Tablet 1 Erythromycin 334 mg. mg. Stearate (each tablet contains erythromycin stearate equivalent to 250 mg. of Erythromycin Note: For other variants of export items, norms may be worked out on a pro-rata basis. Effect of the Public Notice: Standard Input Output Norm appearing under A-222 is amended as above with immediate effect. SANTOSH KUMAR SARANGI, Director General of Foreign Trade Ex-officio Addl. Secy. Uploaded by Dte. of Printing at Government of India Press, Ring Road, Mayapuri, New Delhi-110064 and Published by the Controller of Publications, Delhi-110054.

Continue your research

Related Documents from Ministry of Commerce and Industry